The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival—Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL
Open accessAbstract
PURPOSE: To evaluate volumetric magnetic resonance (MR) imaging for predicting recurrence-free survival (RFS) after neoadjuvant chemotherapy (NACT) of breast cancer and to consider its predictive performance relative to pathologic complete response (PCR). MATERIALS AND METHODS: This HIPAA-compliant prospective multicenter study was approved by institutional review boards with written informed consent. Women with breast tumors 3 cm or larger scheduled for NACT underwent dynamic contrast-enhanced MR imaging before treatment (examination 1), after one cycle (examination 2), midtherapy (examination 3), and before surgery (examination 4). Functional tumor volume (FTV), computed from MR images by using enhancement thresholds, and change from baseline (ΔFTV) were measured after one cycle and before surgery. Association of RFS with FTV was assessed by Cox regression and compared with association of RFS with PCR and residual cancer burden (RCB), while controlling for age, race, and hormone receptor (HR)/ human epidermal growth factor receptor type 2 (HER2) status. Predictive performance of models was evaluated by C statistics. RESULTS: Female patients (n = 162) with FTV and RFS were included. At univariate analysis, FTV2, FTV4, and ΔFTV4 had significant association with RFS, as did HR/HER2 status and RCB class. PCR approached significance at univariate analysis and was not significant at multivariate analysis. At univariate analysis, FTV2 and RCB class had the strongest predictive performance (C statistic = 0.67; 95% confidence interval [CI]: 0.58, 0.76), greater than for FTV4 (0.64; 95% CI: 0.53, 0.74) and PCR (0.57; 95% CI: 0.39, 0.74). At multivariate analysis, a model with FTV2, ΔFTV2, RCB class, HR/HER2 status, age, and race had the highest C statistic (0.72; 95% CI: 0.60, 0.84). CONCLUSION: Breast tumor FTV measured by MR imaging is a strong predictor of RFS, even in the presence of PCR and RCB class. Models combining MR imaging, histopathology, and breast cancer subtype demonstrated the strongest predictive performance in this study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer Subtypes
Carey, L. A., Dees, E. C., Sawyer, L., Gatti, L., Moore, D. T., Collichio, F., Ollila, D. W., Sartor, C. I., Graham, M. L., & Perou, C. M. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1109 · Cited by 2,087
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
Symmans, W. F., Peintinger, F., Hatzis, C., Rajan, R., Kuerer, H., Valero, V., Assad, L., Poniecka, A., Hennessy, B., Green, M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.6823 · Cited by 1,654
Uno, H., Cai, T., Pencina, M. J., D'Agostino, R. B., & Wei, L. J. (2011) · Statistics in Medicine · doi:10.1002/sim.4154 · Cited by 1,535 · cited 1×
“To assess the predictive performance of models, a c -statistic modified to account for censoring was computed, together with a 95% confidence interval (21).”
Applied Survival Analysis: Regression Modeling of Time‐to‐Event Data
Hosmer, D. W., Lemeshow, S., & May, S. (2008) · Wiley Series in Probability and Statistics · doi:10.1002/9780470258019 · Cited by 1,298
Hudis, C. A., Barlow, W. E., Costantino, J. P., Gray, R. J., Pritchard, K. I., Chapman, J.-A. W., Sparano, J. A., Hunsberger, S., Enos, R. A., Gelber, R. D., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.3523 · Cited by 864
Hylton, N. M., Blume, J. D., Bernreuter, W. K., Pisano, E. D., Rosen, M. A., Morris, E. A., Weatherall, P. T., Lehman, C. D., Newstead, G. M., Polin, S., et al. (2012) · Radiology · doi:10.1148/radiol.12110748 · Cited by 502
Self-citationEsserman, L. J., Berry, D. A., DeMichele, A., Carey, L., Davis, S. E., Buxton, M., Hudis, C., Gray, J. W., Perou, C., Yau, C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.2779 · Cited by 438
Self-citationYeh, E., Slanetz, P., Kopans, D. B., Rafferty, E., Georgian-Smith, D., Moy, L., Halpern, E., Moore, R., Kuter, I., & Taghian, A. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.184.3.01840868 · Cited by 403
Marinovich, M. L., Houssami, N., Macaskill, P., Sardanelli, F., Irwig, L., Mamounas, E. P., von Minckwitz, G., Brennan, M. E., & Ciatto, S. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs528 · Cited by 382
The I-SPY 1 TRIAL Investigators, Esserman, L. J., Berry, D. A., Cheang, M. C. U., Yau, C., Perou, C. M., Carey, L., DeMichele, A., Gray, J. W., Conway-Dorsey, K., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1895-2 · Cited by 362
Self-citationPartridge, S. C., Gibbs, J. E., Lu, Y., Esserman, L. J., Tripathy, D., Wolverton, D. S., Rugo, H. S., Hwang, E. S., Ewing, C. A., & Hylton, N. M. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.184.6.01841774 · Cited by 278
Self-citationAccuracy of MRI in the Detection of Residual Breast Cancer After Neoadjuvant Chemotherapy
Rosen, E. L., Blackwell, K. L., Baker, J. A., Soo, M. S., Bentley, R. C., Yu, D., Samulski, T. V., & Dewhirst, M. W. (2003) · American Journal of Roentgenology · doi:10.2214/ajr.181.5.1811275 · Cited by 278
Lobbes, M. B. I., Prevos, R., Smidt, M., Tjan-Heijnen, V. C. G., van Goethem, M., Schipper, R., Beets-Tan, R. G., & Wildberger, J. E. (2013) · Insights into Imaging · doi:10.1007/s13244-013-0219-y · Cited by 237
Londero, V., Bazzocchi, M., Del Frate, C., Puglisi, F., Di Loreto, C., Francescutti, G., & Zuiani, C. (2004) · European Radiology · doi:10.1007/s00330-004-2246-z · Cited by 232
Croshaw, R., Shapiro-Wright, H., Svensson, E., Erb, K., & Julian, T. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1919-5 · Cited by 178
Weatherall, P. T., Evans, G. F., Metzger, G. J., Saborrian, M. H., & Leitch, A. M. (2001) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1124 · Cited by 162
Self-citationDenis, F., Desbiez-Bourcier, A. V., Chapiron, C., Arbion, F., Body, G., & Brunereau, L. (2004) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2004.07.024 · Cited by 123
Shin, H. J., Kim, H. H., Ahn, J.-H., Kim, S.-B., Jung, K. H., Gong, G. Y., Son, B. H., & Ahn, S. H. (2011) · British Journal of Radiology · doi:10.1259/bjr/74430952 · Cited by 123
Wasser, K., Sinn, H., Fink, C., Klein, S., Junkermann, H., Lüdemann, H., ZUNA, I., & Delorme, S. (2003) · European Radiology · doi:10.1007/s00330-002-1730-6 · Cited by 114
Stephens, T. W. (2012) · Yearbook of Diagnostic Radiology · doi:10.1016/j.yrad.2012.03.050 · Cited by 99
Warren, R. M. L., Bobrow, L. G., Earl, H. M., Britton, P. D., Gopalan, D., Purushotham, A. D., Wishart, G. C., Benson, J. R., & Hollingworth, W. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601710 · Cited by 87
Ko, E. S., Han, B., Kim, R. B., Ko, E. Y., Shin, J. H., Hahn, S. Y., Nam, S. J., Lee, J. E., Lee, S. K., Im, Y., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-2925-6 · Cited by 75
Montemurro, F., Martincich, L., Rosa, G. D., Cirillo, S., Marra, V., Biglia, N., Gatti, M., Sismondi, P., Aglietta, M., & Regge, D. (2005) · European Radiology · doi:10.1007/s00330-005-2656-6 · Cited by 34
Oksa, S., Parkkola, R. K., Luukkaala, T. H., & Maenpaa, J. U. (2009) · Acta Radiologica · doi:10.1080/02841850903168083 · Cited by 16
Cited by
Artificial intelligence in cancer imaging: Clinical challenges and applications
Bi, W. L., Hosny, A., Schabath, M. B., Giger, M. L., Birkbak, N. J., Mehrtash, A., Allison, T., Arnaout, O., Abbosh, C., Dunn, I. F., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21552 · Cited by 1,846
Mann, R. M., Cho, N., & Moy, L. (2019) · Radiology · doi:10.1148/radiol.2019182947 · Cited by 917
Giger (2018) · doi:10.1016/j.jacr.2017.12.028 · Cited by 634
Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival
Magbanua, M. J. M., Swigart, L. B., Wu, H.-T., Hirst, G. L., Yau, C., Wolf, D. M., Tin, A., Salari, R., Shchegrova, S., Pawar, H., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2020.11.007 · Cited by 462
Self-citationShukla‐Dave, A., Obuchowski, N. A., Chenevert, T. L., Jambawalikar, S., Schwartz, L. H., Malyarenko, D., Huang, W., Noworolski, S. M., Young, R. J., Shiroishi, M. S., et al. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26518 · Cited by 389
Self-citation
Metadata
- Authors
- Hylton, N. M., Gatsonis, C. A., Rosen, M. A., Lehman, C. D., Newitt, D. C., Partridge, S. C., Bernreuter, W. K., Pisano, E. D., Morris, E. A., Weatherall, P. T., Polin, S. M., Newstead, G. M., Marques, H. S., Esserman, L. J., Schnall, M. D., & For the ACRIN 6657 Trial Team and I-SPY 1 TRIAL Investigators
- Venue
- Radiology
- Published
- 2016-04
- Volume
- 279
- Issue
- 1
- Pages
- 44-55
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2182711918
- Cited by
- 276
- References
- 25
- FWCI
- 12.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.